Literature DB >> 28396947

Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose?

Hugo J A Adams1, Thomas C Kwee2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28396947     DOI: 10.1007/s00277-017-2990-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group.

Authors:  Juliano Júlio Cerci; Mateos Bogoni; Valeria Buccheri; Elba Cristina Sá de Camargo Etchebehere; Talita Maira Bueno da Silveira; Otavio Baiocchi; Carlos de Araujo Cunha Pereira Neto; Marcelo Tatit Sapienza; Jose Flavio Gomes Marin; José Cláudio Meneghetti; Yana Novis; Carmino Antonio de Souza; Carlos Chiattone; Marcia Torresan; Celso Dario Ramos
Journal:  Hematol Transfus Cell Ther       Date:  2018-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.